[PDF] Top 20 Argentina: La participación ciudadana como desafío

... the second Hsct showed a significant impact on better survival ...received second Hsct while in a non-remission status died; in particular, seven of these ten died within 8 months after ...for ... See full document

... acute leukemia were treated with prophylactic granulocyte colony stimulat- ing factor-primed peripheral blood stem cells ...acute leukemia who receive HLA-mismatched/haploidentical HSCT. A ... See full document

... This study investigated clinical course of 53 consecutive patients who underwent AHSCT for adult ALL at Istanbul University Istanbul Medical Faculty between October 2003 to January 2011. Fifty-three patients (35 male, ... See full document

... at transplantation was associated with an increased risk of ...[28]. Second, we included not only hematological and extramedullary re- lapse but also molecular relapse in our ...post- ... See full document

... HLH relapse (n ⫽ 5). Transplant- related toxicity essentially consisted in veno-occlusive disease, which occurred in 28% of transplants and was associated with young age, haploidentical transplan- tation, ... See full document

... Abstract: Relapse rate of core-binding factor (CBF) acute myeloid leukemia (AML) is higher than ...of hematopoietic stem cell transplantation (HSCT) as post-remission therapy for ... See full document

... The cumulative incidences of CMV infection, CMV high-grade infection, CMV disease and late CMV disease were compared between NM-HCT and M-HCT groups, with subsequent transplantation or death considered competing ... See full document

... as single agent or in com- bination with hypomethylating agents have shown potential benefits in patients who are not candidates for intensive therapy as well as those with relapsed ... See full document

... ranges. Because of suspicion of noncompliance with the gluten-free diet despite negative serologic testing (anti- gliadin IgG, IgA, tissue transglutaminase IgA, and total serum IgA levels within reference ranges), an ... See full document

... hours after infusion as the highest temperature on that day, which dropped back to normal level ...therapy. After treatment with dexamethasone (10 mg/day) for 3 days, her fever and urinary incontinence ... See full document

... lymphocytes after allogeneic hematopoietic stem cell transplantation have an important role not only on the prevention of serious infec- tions in the early transplantation ... See full document

... significantly greater than that of patients without the MK. In summary, cytogenetic abnormalities remain the most important predictor of treatment outcome in MDS patients. MK + , which was not considered as a separate ... See full document

... with leukemia relapse after ...T cell from bone marrow using specific T cell isolation ...any relapse indications (n = 5, termed as group A) and MRD + patients or relapsed ... See full document

... All patients were screened for invasive aspergillosis using serum galactomannan before HSCT and twice weekly after HSCT until they were discharged. During the follow-up patients were screened with serum galac- ... See full document

... HSCT therapy is more effective than autologous HSCT therapy. 8 In recent years, other treatments have been used for BPDCN, especially for recurrent/refractory (R/R) patients. These new treatments and clinical trials for ... See full document

... The DNA methylation profile between donors and all time points of recipients revealed a strong hyper-methylation of HSPCs after transplant. In particu- lar, we found in all cases that hyper-methylated ... See full document

... hairy cell leukemia from 2012 or earlier, as seen in the bone marrow biop- ...hairy cell leukemia ...hairy cell leukemia ...with allogeneic stem cell ... See full document

... disease relapse, graft rejection and GVHD, or donor cell hematologic malignancies [17, 18] and is helpful for determining appropriate intervention or ther- apy ...SCL after alloHSCT, nei- ther ... See full document

... Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment for intermedi- ate/high-risk MDS and acute myeloid leukemia ...poietic stem ... See full document

... function. Stem cell sources included matched related donors (MRDs) (HLA identical sibling), donor peripheral blood stem cells we- re mobilized with granulocyte colony-stimulat- ing ...blood ... See full document